# Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

> **NCT00002608** · PHASE2 · COMPLETED · sponsor: **Ottawa Regional Cancer Centre** · enrollment: 30 (estimated)

## Conditions studied

- Adrenocortical Carcinoma
- Brain and Central Nervous System Tumors
- Head and Neck Cancer
- Liver Cancer
- Malignant Mesothelioma
- Pheochromocytoma
- Sarcoma

## Interventions

- **DRUG:** cisplatin
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** tamoxifen citrate
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002608
- **Lead sponsor:** Ottawa Regional Cancer Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-05
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002608, "Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00002608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*